title: Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy.
abstract: BACKGROUND
  The natural history of focal splenic lesions in paediatric Gaucher disease (GD) is unknown and these lesions are thought to persist despite enzyme replacement therapy (ERT).
  
  
  OBJECTIVE
  To assess the prevalence, evolution and resolution of splenic nodules in a cohort of paediatric Gaucher patients treated with ERT.
  
  
  METHODS
  The US findings in 37 children with GD were retrospectively reviewed. A total of 28 children underwent serial abdominal US examinations as part of their initial assessment and during routine follow-up. All patients received ERT.
  
  
  RESULTS
  Six children (21%) had splenic nodules on US examination, either at presentation or on follow-up examination. In all six patients, the nodules had resolved on follow-up imaging, with resolution taking 17 months to 4 years 8 months. Two sets of siblings developed nodules that resolved over a similar time period.
  
  
  CONCLUSIONS
  Disappearance of focal splenic lesions in children with GD during follow-up has not been previously reported. The development of new focal splenic lesions in children with GD whilst on ERT has not been previously documented.
authors: Department of Radiology, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK. schipping@hotmail.com
authors: Samantha
authors: S
authors: Chippington
authors: Kieran
authors: K
authors: McHugh
authors: Ashok
authors: A
authors: Vellodi
mesh_terms: D017485:1-Deoxynojirimycin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D005776:Gaucher Disease / Q000150:complications / Q000188:drug therapy*; D005962:Glucosylceramidase / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D008297:Male; D012189:Retrospective Studies; D013154:Spleen / Q000000981:diagnostic imaging* / Q000473:pathology; D013158:Splenic Diseases / Q000175:diagnosis* / Q000209:etiology; D013163:Splenomegaly / Q000209:etiology / Q000473:pathology; D014463:Ultrasonography
chemical_list: D004791:Enzyme Inhibitors; D017485:1-Deoxynojirimycin; C059896:miglustat; D005962:Glucosylceramidase; C090568:imiglucerase